Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning

Neuro-Oncology

Volumn 12, Issue 11, 2010, Pages 1187-1192

  Nagai, Aiko ^a   Shibamoto, Yuta ^a   Mori, Yoshimasa ^b   Hashizume, Chisa ^b   Hagiwara, Masahiro ^b   Kobayashi, Tatsuya ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

Author keywords

Brain metastasis; Frame fixed; Gamma knife; Radiosurgery; Thin slice MRI

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOSURGERY; SURGERY, COMPUTER-ASSISTED;

EID: 78650155705     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq084     Document Type: Article

References (32)

1. Wen PY, BlackPM, Loeffler JS. Cancer: principles and practice of oncology. In: DeVita,V, Hellman, S, Rosenberg, SA, eds. Metastatic Brain Cancer. 6th ed. Philadelphia: Lippincott,Williams, &Wilkins; 2001:2655-2670.
2. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. Am J Neuroradiol. 1991;12:293-300.
3. Suzuki K, Yamamoto M, Hasegawa Y, et al. Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer. Lung Cancer. 2004;46:357-360.
4. SchellingerPD,MeinckHM, Thron A. Diagnostic accuracy ofMRI compared to CCT in patients with brainmetastases. J Neurooncol. 1999;44:275-281.
5. Akeson P, Larsson EM, Kristoffersen DT, Jonsson E, Holtas S. Brain metastases-comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging. Acta Radiol. 1995;36:300-306.
6. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. Am J Neuroradiol. 1990;11:785-791.
7. Davey P. Brain metastases: treatment options to improve outcomes. CNS Drugs. 2002;16:325-338.
8. Kaal EC, Taphoorn MJ, Vecht CJ. Symptomatic management and imaging of brain metastases. J Neurooncol. 2005;75:15-20.
9. Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol. 2006;13:674-681.
10. Soffietti R, Costanza A, Laguzzi E, Nobile M, Ruda R. Radiotherapy and chemotherapy of brain metastases. J Neurooncol. 2005;75: 31-42.
11. Kaal EC, Niel CG, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol. 2005;4:289-298.
12. McPherson CM, Suki D, Feiz-Erfan I, et al. Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases [published online ahead of print February 14, 2010]. Neuro-Oncology. doi:10.1093/neuonc/noq005.
13. Shibamoto Y, Sugie C, Iwata H. Radiotherapy for metastatic brain tumors. Int J Clin Oncol. 2009;14:281-288.
14. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485-1489.
15. Chougule PB, Burton-Williams M, Saris S, et al. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys. 2000;48(suppl):114.
16. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483-2491.
17. Shibamoto Y, Baba F, Oda K, et al. Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys. 2008;72:1168-1173.
18. Kwon AK, Dibiase SJ, Wang B, Hughers SL, Milcarek B, Zhu Y. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer. 2009;115:890-898.
19. Shalen PR, Hayman LA, Wallace S, Handel SF. Protocol for delayed contrast enhancement in computed tomography. Radiology. 1981; 139:397-401.
20. Sze G, Stimac GK, Bartlett C, et al. Multicenter study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with spinal tumors. Am J Neuroradiol. 1990;11:967-974.
21. Mastronardi L, Lunardi P, Puzzilli F, Schettini G, Lo Bianco F, Ruggeri A. The role of MRI in the surgical selection of cerebral metastases. Zentralbl Neurochir. 1999;60:141-145.
22. Yuh WT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Am J Neuroradiol. 1992;13:335-345.
23. Yuh WT, Fisher DJ, Runge VM, et al. Phase III multicenter trial of highdose gadoteridol in MR evaluation of brain metastases. Am J Neuroradiol. 1994;15:1037-1051.
24. Seute T, Leffers P, ten Velde GP, Twijinstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer. 2008;112:1827-1834.
25. Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. Am J Neuroradiol. 1995;16: 373-380.
26. Sze G, Johnson C, Kawamura Y, et al. Comparison of single- and tripledose contrast material in the MR screening of brain metastases. Am J Neuroradiol. 1998;19:821-828.
27. Ginsberg LE, Lang FF. Neuroradiologic screening for brain metastases- can quadruple dose gadolinium be far behind? Am J Neuroradiol. 1998;19:829-830.
28. Haba D, Pasco Papon A, Tanguy JY, Burtin P, Aube C, Caron-Poitreau C. Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors. Eur Radiol. 2001;11:117-122.
29. Elster AD, Chen MY. Can nonenhancing white matter lesions in cancer patients be disregarded? Am J Neuroradiol. 1992;13:1309-1315.
30. Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K, et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol. 2003;38:415-422.
31. Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastases. J ClinOncol. 2006;24:1295-1303.
32. Donahue BR, Goldberg JD, Golfinos JG, et al. Importance of MR technique for stereotactic radiosurgery. Neurooncology. 2003;5: 268-274.